Shanghai Zero Hypothesis Information Technology
AI-powered medical intelligence and content generation SaaS.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Series B | |
| Total Funding | 000k | ||
Shanghai Zero Hypothesis Information Technology Co., Ltd., also known as Nullht, is a technology company founded in 2019 that develops intelligent medical products. The firm is dedicated to enhancing the knowledge transfer process within the academic promotion chain for pharmaceuticals by integrating data technology with medical expertise.
The company's core offering is the KnowS series, a SaaS product line that intelligently generates professional medical information and content on a large scale. This series is designed for medical institutions and pharmaceutical companies, understanding their specific use cases for professional information. The software suite includes tools like 'Evidence' for medical reading analysis, 'Express' for content generation, and 'Competition', a tool for automated professional analysis of drug comparisons. The primary goal of these products is to promote the commercialization of innovative drugs through more efficient and professional knowledge transfer.
Nullht's business model is centered on providing its SaaS products to professionals at pharmaceutical companies and healthcare facilities. The company operates in the Discovery Tools segment of the healthcare industry. The core team consists of professionals with diverse backgrounds from institutions such as Tsinghua, Fudan, Jiaotong, and ECUST, including their medical and pharmaceutical schools, who specialize in combining medical knowledge with data analysis techniques.
As a privately held company, Nullht has secured funding from several institutional investors. It completed a Series B funding round on September 11, 2024, led by Zhongbojuli. Other investors include Zhongbo Capital, Ennovation Ventures, WEquick, Hongshan Capital Group, and Oriza Holdings.
Keywords: medical intelligence, pharmaceutical technology, SaaS, healthcare data, academic promotion, drug commercialization, medical content generation, clinical analysis tools, data science, AI in healthcare, pharma business intelligence, KnowS, Evidence, Express, Competition, medical information services